HOUSE-BILL 7352: H.R.7352 - PASTEUR Act of 2026
AI-Powered Summary
HOUSE-BILL 7352 aims to enhance the availability and appropriate use of innovative antimicrobial drugs, directly impacting individuals' access to lifesaving medications and improving patient care, especially for those with multi-drug-resistant infections. The bill establishes a grant program for healthcare facilities to implement antimicrobial stewardship programs, thereby supporting individuals' rights to quality healthcare. It raises constitutional concerns regarding the broad authority granted to the Secretary of Health and Human Services, which may lead to questions about executive power limits in healthcare and transparency issues related to pricing and manufacturer information. Key provisions include the ability for the Secretary to enter contracts with antimicrobial sponsors, a scoring system to prioritize effective drugs, and requirements for educational strategies to inform healthcare professionals and patients. The implementation of these provisions is expected to streamline access to new treatments while enhancing individual rights to understand their medical options. Overall, the bill addresses critical public health interests by combating antimicrobial resistance and ensuring effective treatment availability, with potential implications for healthcare access and government accountability.
Demographic Impact Analysis
Summary
Overall Constitutional Implications
The PASTEUR Act has significant implications for public health and individual rights, particularly in enhancing access to necessary medical treatments for vulnerable populations. By addressing antimicrobial resistance, the bill aims to protect the health of individuals across various demographic groups, thereby supporting the government's role in safeguarding public health.
Key Individual Rights Affected
- Right to Health Care
- Equal Protection under the Law
- Due Process Rights
Constitutional Provisions
- 14th Amendment - Equal Protection Clause
- Preamble - General Welfare
Potential Constitutional Challenges
While the bill promotes public health, there may be challenges regarding equitable access to treatments, particularly for low-income individuals and racial minorities. If disparities arise in the implementation of the program, it could lead to equal protection concerns. Additionally, the collection of demographic data must be handled carefully to avoid discrimination.
Summary
The PASTEUR Act of 2026 aims to improve access to innovative antimicrobial drugs, particularly benefiting vulnerable populations such as infants and seniors. While it supports public health initiatives, careful attention must be paid to ensure equitable access and avoid potential discrimination, aligning with constitutional principles of equal protection and due process.
Constitutional Analysis
This bill appears to align with constitutional principles. The proposed legislation operates within the established framework of constitutional authority and does not appear to conflict with fundamental rights or the separation of powers.
Analysis generated using AI-powered review of constitutional principles and legal precedents.
Take Action
Text 50409
💡 How to use:
These links will start a conversation with ResistBot. When prompted, mention H.R. 7352 to reference this bill.
Contact Your Representatives
Write to YOUR elected officials about this bill
Rate This Bill
Sign in to save a private rating for this bill and track your civic engagement over time.
Sign In FreeTimeline
February 4, 2026
Bill Introduced
Current
Referred to Committee
June 12, 2026
Last Updated
Ask the Constitutional AI About This Bill
Sign in free to chat with our constitutional analysis AI about this bill — get plain-English explanations, constitutional concerns, and demographic impact estimates personalized to you.
Sign In Free to Chat